Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
National Philanthropic Trust

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 September 2007:
Vol. 317. no. 5844, pp. 1554 - 1557
DOI: 10.1126/science.1144603
Prev | Table of Contents | Next

Reports

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

Marijn van der Neut Kolfschoten,1 Janine Schuurman,2 Mario Losen,3 Wim K. Bleeker,2 Pilar Martínez-Martínez,3 Ellen Vermeulen,1 Tamara H. den Bleker,1 Luus Wiegman,2 Tom Vink,2 Lucien A. Aarden,1 Marc H. De Baets,3,4 Jan G.J. van de Winkel,2,5 Rob C. Aalberse,1* Paul W. H. I. Parren2*

Antibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4 antibodies are dynamic molecules that exchange Fab arms by swapping a heavy chain and attached light chain (half-molecule) with a heavy-light chain pair from another molecule, which results in bispecific antibodies. Mutagenesis studies revealed that the third constant domain is critical for this activity. The impact of IgG4 Fab arm exchange was confirmed in vivo in a rhesus monkey model with experimental autoimmune myasthenia gravis. IgG4 Fab arm exchange is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 antibodies.

1 Sanquin Research—AMC Landsteiner Laboratory, Department of Immunopathology, Plesmanlaan 125, 1066 CX Amsterdam, the Netherlands.
2 Genmab, Yalelaan 60, 3584 CM Utrecht, the Netherlands.
3 Department of Neuroscience, Institute of Mental Health and Neuroscience, University of Maastricht, Maastricht, the Netherlands.
4 Neuroimmunology Group, Biomedical Research Institute (BIOMED) Hasselt University, Diepenbeek, Belgium.
5 Immunotherapy Laboratory, Department of Immunology, University Medical Center, Utrecht, the Netherlands.

* To whom correspondence should be addressed. E-mail: r.aalberse{at}sanquin.nl (R.C.A.); p.parren{at}genmab.com (P.W.H.I.P.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
R. Engelmann, J. Brandt, M. Eggert, K. Karberg, A. Krause, G. Neeck, and B. Mueller-Hilke (2008)
Rheumatology
   Abstract »    Full Text »    PDF »
Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms.
J. Wypych, M. Li, A. Guo, Z. Zhang, T. Martinez, M. J. Allen, S. Fodor, D. N. Kelner, G. C. Flynn, Y. D. Liu, et al. (2008)
J. Biol. Chem. 283, 16194-16205
   Abstract »    Full Text »    PDF »
Treatment of Myasthenia Gravis by Preventing Acetylcholine Receptor Modulation.
M. LOSEN, P. MARTINEZ-MARTINEZ, M. PHERNAMBUCQ, J. SCHUURMAN, P. W.H.I. PARREN, and M. H. DE BAETS (2008)
Ann. N.Y. Acad. Sci. 1132, 174-179
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)